Patent · US Active

Antibodies that bind to c-type lectin domain family 2 member d (CLEC2D)

US11827710B2 · kind B2 · utility

0Cited by

7References

19Claims

0Family size

Assignee

Zumutor Biologics Inc. · US

Inventors

Kavitha Iyer Rodrigues · Bengaluru, IN
Maloy Ghosh · Kanchinakote, IN
Sunit Maity · Kanchinakote, IN
Yogendra Manjunath Bangalore MUNIRAJU · Kanchinakote, IN
Sathyabalan Murugesan · Bengaluru, IN
Sanghamitra Bhattacharjee · Kanchinakote, IN
Vivek Halan · Viralimalai, IN
Subhra Prakash Chakrabarty · Survanagiri, IN
Ashvini Kumar Dubey · Kanchinakote, IN
Anurag TIWARI · Sidhauli, IN
Kirthana Mysore Vasudevarao SINDHE · Kanchinakote, IN
Pallavi LAHIRI · Kanchinakote, IN
Sahana Bhima Rao · Kanchinakote, IN
Prachi · Kanchinakote, IN
Shruti SRIVASTAVA · Kanchinakote, IN
Rao Shreesha RAMESH · Kanchinakote, IN
Bharath Ravindra Shenoy · Kanchinakote, IN
Nikitha MARKANDA · Kanchinakote, IN
Bhagyashree DIKEY · Kanchinakote, IN
Bairavabalakumar Natarajan · Chennai, IN

Key dates

Filing date	Feb 10, 2020
Grant date	Nov 28, 2023
Priority date	—
Expiry date	Dec 4, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to novel anti-CLEC2D antibodies and related compositions and methods of use thereof. These antibodies are used as therapeutics, and in prognostic and diagnostic applications in various cancers and other diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.